home / stock / inm / inm news

INM News and Press, InMed Pharmaceuticals Inc. From 09/05/25

Stock Information
Company Name: InMed Pharmaceuticals Inc.
Stock Symbol: INM
Market: NASDAQ
Website: inmedpharma.com
Menu
INM INM Quote INM Short INM News INM Articles INM Message Board
Get INM Alerts

News, Short Squeeze, Breakout and More Instantly...
INM - InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announ...
INM - InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025

Long-term INM-901 treatment in preclinical studies in advanced disease continues to show multi-modal activity Vancouver, British Columbia--(Newsfile Corp. - July 28, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipe...

INM - InMed Pharmaceuticals registers 3.9M shares for resale

2025-07-09 17:38:21 ET More on InMed Pharmaceuticals InMed Pharmaceuticals announces $5M private placement Financial information for InMed Pharmaceuticals Read the full article on Seeking Alpha For further details see: InMed Pharmaceuticals registers 3.9M...

INM - InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - InMed Pharmaceuticals Inc.  (NASDAQ: INM)  (" InMed " or the " Company "), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, ...
INM - InMed Pharmaceuticals announces $5M private placement

2025-06-25 08:54:10 ET More on InMed Pharmaceuticals Financial information for InMed Pharmaceuticals Read the full article on Seeking Alpha For further details see: InMed Pharmaceuticals announces $5M private placement

INM - InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - InMed Pharmaceuticals Inc.  (NASDAQ: INM)  (" InMed " or the " Company "), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, ...

INM - BioMedNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer's Neuroinflammation Model

2025-06-24 14:22:17 ET InMed Pharmaceuticals (NASDAQ: INM) , a pharmaceutical company developing small molecule drug candidates for diseases with high unmet medical needs, announced new preclinical data showing that INM-901 significantly reduces inflammation in ex vivo models of neuroin...
INM - Midday Market Notes: June 24, 2025

2025-06-24 11:57:57 ET DENVER, Colo., Jun 24, 2025 ( 247marketnews.com )- Nektar Therapeutics (NASDAQ:NKTR) is one of today’s headliners , which surged in early trading following breakout data from its REZOLVE‑AD Phase 2b study for rezpegaldesleukin in atop...

INM - InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study

Demonstrates statistically significant reduction of pro-inflammatory cytokines, including IL-6, IL-1β, IL-2, and KC/Gro Significantly reduces levels of inflammasome marker, NLRP3, a key contributor to neurodegeneration Reduces key pro-inflammatory markers, independent of amyloid beta or ...

INM - InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA

Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc.  (NASDAQ: INM)  (" InMed " or the " Company "), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, ...
Previous 10 Next 10